Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Schulman KA, Greicius MD, Richman B. Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval? JAMA 2021 Jul 19. pii: 2782333. doi: 10.1001/jama.2021.11768.
PMID: 34279572


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016